Enhanced neurotrophic distribution, cell signaling and neuroprotection following substantia nigral versus striatal delivery of AAV2-NRTN (CERE-120)
Authors:
- Lamar BrownLBLamar Brown
- Brian R. KruegelBKBrian R. Kruegel
- Alistair WilsonAWAlistair Wilson
- Malú G. TanseyMTMalú G. Tansey
- Fred H. GageFGFred H. Gage
- Eugene M. JohnsonEJEugene M. Johnson
- Raymond T. BartusRBRaymond T. Bartus
- 1 October 2013
- journal article
- Published by Elsevier in Neurobiology of Disease
- Vol. 58, 38-48
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Advancing neurotrophic factors as treatments for age-related neurodegenerative diseases: developing and demonstrating “clinical proof-of-concept” for AAV-neurturin (CERE-120) in Parkinson's diseaseNeurobiology of Aging, 2013
- Translating the therapeutic potential of neurotrophic factors to clinical ‘proof of concept’: A personal saga achieving a career-long questNeurobiology of Disease, 2012
- Properly scaled and targeted AAV2-NRTN (neurturin) to the substantia nigra is safe, effective and causes no weight loss: Support for nigral targeting in Parkinson's diseaseNeurobiology of Disease, 2011
- Bioactivity of AAV2‐neurturin gene therapy (CERE‐120): Differences between Parkinson's disease and nonhuman primate brainsMovement Disorders, 2010
- Clinical progression in Parkinson disease and the neurobiology of axonsAnnals of Neurology, 2010
- Intracellular signalling pathways in dopamine cell death and axonal degeneration2010
- Time‐course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6‐hydroxydopamine in the rat: new clues from an old modelEuropean Journal of Neuroscience, 2007
- Protective effects of intracerebral adenoviral-mediated GDNF gene transfer in a rat model of Parkinson's diseaseParkinsonism & Related Disorders, 2003
- Dopaminergic Neurons Protected from Degeneration by GDNF Gene TherapyScience, 1997
- Glial cell line‐derived neurotrophic factor supports survival of injured midbrain dopaminergic neuronsJournal of Comparative Neurology, 1995